83 related articles for article (PubMed ID: 10888103)
1. A strategy for inducing immune tolerance to valve endothelial cells through gene transfer.
Li Y; McCormack AM; Brand NJ; Yacoub MH
J Heart Valve Dis; 2000 May; 9(3):439-44. PubMed ID: 10888103
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Fas ligand does not confer immune privilege to a pancreatic beta tumor cell line (betaTC-3).
Okamoto S; Takamizawa S; Bishop W; Wen J; Kimura K; Sandler A
J Surg Res; 1999 Jun; 84(1):77-81. PubMed ID: 10334893
[TBL] [Abstract][Full Text] [Related]
3. Human Fas-ligand expression on porcine endothelial cells does not protect against xenogeneic natural killer cytotoxicity.
Matter-Reissmann UB; Sonntag KC; Gilli UO; Leguern C; Schneider MK; Seebach JD
Xenotransplantation; 2004 Jan; 11(1):43-52. PubMed ID: 14962292
[TBL] [Abstract][Full Text] [Related]
4. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
5. In vitro prevention of cell-mediated xeno-graft rejection via the Fas/FasL-pathway in CrmA-transducted porcine kidney cells.
Fujino M; Li XK; Suda T; Hashimoto M; Okabe K; Yaginuma H; Mikoshiba K; Guo L; Okuyama T; Enosawa S; Amemiya H; Amano T; Suzuki S
Xenotransplantation; 2001 May; 8(2):115-24. PubMed ID: 11328582
[TBL] [Abstract][Full Text] [Related]
6. Fas Ligand gene transfer enhances the survival of tissue-engineered chondrocyte allografts in mini-pigs.
Xie GH; Wang SJ; Wang Y; Zhang Y; Zhang HZ; Jin S; Wang QF; Liu ZC; Ge HL
Transpl Immunol; 2008 May; 19(2):145-51. PubMed ID: 18503890
[TBL] [Abstract][Full Text] [Related]
7. Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.
O'Connell J; Bennett MW; O'Sullivan GC; Roche D; Kelly J; Collins JK; Shanahan F
J Pathol; 1998 Nov; 186(3):240-6. PubMed ID: 10211111
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
Huerta-Yepez S; Vega M; Garban H; Bonavida B
Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
[TBL] [Abstract][Full Text] [Related]
9. Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.
Elnemr A; Ohta T; Yachie A; Kayahara M; Kitagawa H; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Miwa K
Int J Oncol; 2001 Jan; 18(1):33-9. PubMed ID: 11115536
[TBL] [Abstract][Full Text] [Related]
10. Utility of adenovirus-mediated Fas ligand and bcl-2 gene transfer to modulate rat liver allograft survival.
Wang DS; Li Y; Dou KF; Li KZ; Song ZS
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):505-10. PubMed ID: 17085333
[TBL] [Abstract][Full Text] [Related]
11. Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells.
Ragnarsson GB; Mikaelsdottir EK; Vidarsson H; Jónasson JG; Olafsdóttir K; Kristjánsdóttir K; Kjartansson J; Ogmundsdóttir HM; Rafnar T
Br J Cancer; 2000 Dec; 83(12):1715-21. PubMed ID: 11104571
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects on the inhibition of human CD8+ cytotoxic T lymphocytes-mediated killing against xenograft cells by coexpression of membrane-bound Human FasL and decoy Fas antigen.
Tanemura M; Kawamoto K; Ito T; Uchikoshi F; Shimada K; Nishida T; Matsuda H
Transplant Proc; 2005 Dec; 37(10):4607-9. PubMed ID: 16387181
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of anti-fas ribozyme on apoptosis of mouse T cells.
Zhang M; Chen ZC; Tian L; Liu F; Liu LB; You Y; Zou P
Ai Zheng; 2005 May; 24(5):520-4. PubMed ID: 15890090
[TBL] [Abstract][Full Text] [Related]
14. Effects of specific antisense oligonucleotide inhibition of Fas expression on T cell apoptosis induced by Fas ligand.
Mao H; Liu Q; Zhang J; Gu H; Wang L; Zhou X; Yin H; Zhang L; Xie F; Jiang G
Int Immunopharmacol; 2007 Dec; 7(13):1714-22. PubMed ID: 17996681
[TBL] [Abstract][Full Text] [Related]
15. FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells.
Imai T; Adachi S; Nishijo K; Ohgushi M; Okada M; Yasumi T; Watanabe K; Nishikomori R; Nakayama T; Yonehara S; Toguchida J; Nakahata T
Oncogene; 2003 Dec; 22(58):9231-42. PubMed ID: 14647441
[TBL] [Abstract][Full Text] [Related]
16. Overexpressed exogenous IL-4 And IL-10 paradoxically regulate allogenic T-cell and cardiac myocytes apoptosis through FAS/FASL pathway.
Furukawa H; Oshima K; Tung T; Cui G; Laks H; Sen L
Transplantation; 2008 Feb; 85(3):437-46. PubMed ID: 18301335
[TBL] [Abstract][Full Text] [Related]
17. Detection of Fas ligand in the bovine oviduct.
Bergqvist AS; Killian G; Erikson D; Hoshino Y; Båge R; Sato E; Rodríguez-Martínez H
Anim Reprod Sci; 2005 Mar; 86(1-2):71-88. PubMed ID: 15721660
[TBL] [Abstract][Full Text] [Related]
18. The role of Fas ligand as an effector molecule in corneal graft rejection.
Stuart PM; Yin X; Plambeck S; Pan F; Ferguson TA
Eur J Immunol; 2005 Sep; 35(9):2591-7. PubMed ID: 16114107
[TBL] [Abstract][Full Text] [Related]
19. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
Elsässer-Beile U; Gierschner D; Welchner T; Wetterauer U
Anticancer Res; 2003; 23(1A):433-7. PubMed ID: 12680244
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic death of infiltrating cells in human cardiac allografts is regulated by IL-2, FASL, and FLIP.
de Groot-Kruseman HA; Baan CC; Zondervan PE; de Weger RA; Niesters HG; Balk AH; Weimar W
Transplant Proc; 2004 Dec; 36(10):3143-8. PubMed ID: 15686714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
